BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.488,57 PKT -0,01 PKT ±0,00 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
31.01.05 Novartis Buy Helvea
27.01.05 Adecco SA Accumulate Helvea
27.01.05 Lonza Buy Helvea
27.01.05 Holcim Neutral Helvea
03.02.05 Novartis Outperformer Sparkasse KölnBonn
27.01.05 Holcim Halten Helaba Trust
26.01.05 Novartis Market Perform William Blair
26.01.05 Lindt In-Line Goldman Sachs
26.01.05 UBS Buy Sarasin Research
26.01.05 Lonza Reduce Sarasin Research
26.01.05 Lindt Neutral Sarasin Research
25.01.05 Swisscom Underweight Lehman Brothers
25.01.05 Holcim Accumulate Helvea
25.01.05 Lonza Overweight JP Morgan
25.01.05 Lindt Neutral Helvea
26.01.05 Nestlé Outperform Credit Suisse First Boston
25.01.05 Adecco SA Accumulate Helvea
25.01.05 Novartis Buy Helvea
25.01.05 UBS Buy Helvea
25.01.05 Novartis Halten LB Baden-Württemberg
25.01.05 Novartis Outperform Goldman Sachs
24.01.05 Novartis Overweight Prudential Securities
24.01.05 Holcim Neutral Sarasin Research
24.01.05 Richemont Outperform Goldman Sachs
25.01.05 Novartis Neutral Sarasin Research
24.01.05 Richemont Neutral Merrill Lynch
24.01.05 Novartis Neutral Sarasin Research
21.01.05 ABB (Asea Brown Boveri) Neutral Sarasin Research
21.01.05 Zurich Insurance Buy Sarasin Research
24.01.05 Lonza Reduce Sarasin Research
21.01.05 Richemont Buy Sarasin Research
24.01.05 Novartis Neutral HypoVereinsbank
24.01.05 ABB (Asea Brown Boveri) Kaufen NATIONAL-BANK
21.01.05 Zurich Insurance Accumulate Helvea
21.01.05 Roche Buy Sarasin Research
21.01.05 Richemont Accumulate Helvea
21.01.05 Novartis Kaufen Helaba Trust
21.01.05 Logitech Accumulate Helvea
24.01.05 Straumann Outperform Credit Suisse First Boston
21.01.05 Holcim Accumulate Helvea